Solid Biosciences Inc.
SLDB
$3.23
-$0.07-2.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -29.87% | -12.78% | -0.48% | 0.52% | -11.67% |
| Total Depreciation and Amortization | -4.88% | -25.01% | -14.29% | -6.10% | 7.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 138.61% | 202.28% | 161.21% | 159.64% | 175.80% |
| Change in Net Operating Assets | 132.14% | 80.75% | 72.72% | -1,157.92% | -140.39% |
| Cash from Operations | -6.19% | 15.44% | 22.64% | 7.50% | 3.88% |
| Capital Expenditure | 56.83% | 76.33% | 66.82% | 65.30% | 49.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -237.78% | -804.80% | -154.36% | -317.15% | -62.71% |
| Cash from Investing | -266.02% | -130.69% | -132.85% | -212.59% | -83.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -422.73% | -240.91% | -- | -- |
| Issuance of Common Stock | 4,000.61% | 61.35% | 56.86% | 58.37% | -95.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,821.75% | 49.96% | 45.76% | 47.53% | -95.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.79% | 154,450.00% | -88.22% | -235.66% | -325.96% |